Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Clinical trial NCT06824194 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06824194
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-18
- Primary completion
- 2027-10-22
- Enrollment
- 2360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.